Treg

The regulatory T cells, formerly known as suppressor T cells, are a subpopulation of T cells that modulate the immune system, maintain tolerance to self-antigens, and prevent autoimmune disease. Tregs are immunosuppressive and generally suppress or downregulate induction and proliferation of effector T cells. Tregs express the biomarkers CD4, FOXP3, and CD25 and are thought to be derived from the same lineage as naïve CD4 cells. Because effector T cells also express CD4 and CD25, Tregs are very difficult to effectively discern from effector CD4+, making them difficult to study. Recent research has found that the cytokine TGFβ is essential for Tregs to differentiate from naïve CD4+ cells and is important in maintaining Treg homeostasis. Mouse models have suggested that modulation of Tregs can treat autoimmune disease and cancer and can facilitate organ transplantation and wound healing. Their implications for cancer are complicated.

Read more in the app

Unleashing Treg cells may lead to treatments for multiple sclerosis

UCI-led study finds unleashing Treg cells may lead to treatments for multiple sclerosis